title: [IgA pemphigus. Successful treatment with mycophenolate mofetil].
abstract: IgA pemphigus is a rare intraepidermal autoimmune disease characterized by the presence of intercellular IgA deposits, intraepidermal acantholysis with infiltration of neutrophils, and circulating IgA autoantibodies against keratinocyte cell surface components. We report for the first time about a patient with IgA pemphigus who was successfully treated with mycophenolate mofetil.
authors.affiliation: Hautklinik, Universitätskinikum Düsseldorf, Düsseldorf.
authors.forename: T
authors.initials: T
authors.lastname: Burchardt
authors.forename: A
authors.initials: A
authors.lastname: Büchau
authors.forename: T
authors.initials: T
authors.lastname: Ruzicka
authors.forename: M
authors.initials: M
authors.lastname: Megahed
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001323:Autoantibodies / Q000276:immunology; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D019085:Fluorescent Antibody Technique, Direct; D019084:Fluorescent Antibody Technique, Indirect; D005500:Follow-Up Studies; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology*; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D010392:Pemphigus / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology*; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D000893:Anti-Inflammatory Agents; D001323:Autoantibodies; D003879:Dermatologic Agents; D007070:Immunoglobulin A; D011239:Prednisolone; D009173:Mycophenolic Acid